Does sucralfate reduce early side effects of pelvic radiation? A double-blind randomized trial

Radiotherapy and Oncology

Volumn 65, Issue 2, 2002, Pages 105-108

  Stellamans, Karin ^a   Lievens, Yolande ^a   Lambin, Philippe ^a   Van Den Weyngaert, Danielle ^b   Van Den Bogaert, Walter ^a   Scalliet, Pierre ^b   Hutsebaut, Liesbeth ^a   Haustermans, Karin ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b AZ Middelheim ^*  (Belgium)

Author keywords

Pelvic irradiation; Side effects; Sucralfate

Indexed keywords

LOPERAMIDE; SUCRALFATE;

ABDOMINAL CRAMP; ARTICLE; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ENDOMETRIUM CARCINOMA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; RECTUM CARCINOMA; UTERINE CERVIX CARCINOMA; WEIGHT REDUCTION; COMPUTER ASSISTED RADIOTHERAPY; FECES INCONTINENCE; PELVIS TUMOR; TIME; TREATMENT OUTCOME;

DOUBLE-BLIND METHOD; FECAL INCONTINENCE; HUMANS; PELVIC NEOPLASMS; RADIOTHERAPY, CONFORMAL; SUCRALFATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036848285     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(02)00281-5     Document Type: Article

References (17)

1. Capizzi R.L., Oster W. Protection of normal tissue from the cytotoxic effects of chemotherapy and radiation by amifostine: clinical experiences. Eur J Cancer. 31:(Suppl 1):1995;8-13.
2. Carter D.L., Hebert M.E., Smink K., et al. Double-blind randomized trial of sucralfate vs. placebo during radical radiotherapy for head and neck cancers. Head Neck. 21:(8):1999;760-766.
3. Cengiz M., Ozyar E., Ozturk D., et al. Sucraflate in the prevention of radiation-induced oral mucositis. J Clin Gastroenterol. 28:1999;40-43.
4. Das U., Lanciano R.M., Movsas B., et al. Efficacy of a belly board device with CT-simulation in reducing small bowel volume within pelvic irradiation fields. Int J Radiat Oncol Biol Phys. 39:(1):1997;67-76.
5. Epstein J.B., Wong F.L. The efficacy of sucralfate suspension in the prevention of oral mucositis due to radiation therapy. Int J Radiat Oncol Biol Phys. 28:1994;693-698.
6. Franzen L., Henriksson R., Littbrand B., et al. Effects of sucralfate on mucositis during and following radiotherapy of malignancies in the head and neck region. Acta Oncol. 34:(2):1995;219-223.
7. Henriksson R., Franzen L., Littbrand B. Prevention and therapy of radiation-induced bowel discomfort. Scand J Gastroenterol. 27:(5191):1992;7-11.
8. Henriksson R., Franzen L., Littbrand B. Effects of sucralfate on acute and late bowel discomfort following radiotherapy of pelvic cancer. J Clin Oncol. 10:1992;969-975.
9. Kiliç D., Egehan I., Ozenirler S., et al. Double-blinded, randomised, placebo-controlled study to evaluate the effectiveness of sulphasalazine in preventing acute gastrointestinal complications due to radiotherapy. Radiother Oncol. 57:2000;125-129.
10. Koelbl O., Richter S., Flentje M. Influence of patient positioning on dose-volume histogram and normal tissue complication probability for small bowel and bladder in patients receiving pelvic irradiation: a prospective study using a 3D planning system and a radiobiological model. Int J Radiat Oncol Biol Phys. 45:(5):1999;1193-1198.
11. Licvens Y., Haustermans K., Van de Weyngaert D., et al. Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomised trial. Radiother Oncol. 47:1998;149-153.
12. Martenson J.A., Bollinger J.W., Sloan J.A., et al. Sucralfate in the prevention of treatment- induced diarrhoea in patients receiving pelvic radiation therapy: a North Central cancer treatment group phase III double-blind placebo-controlled trial. J Clin Oncol. 18:2000;1239-1245.
13. O'Brien P.C., Franklin I., Dear K., et al. A phase III double-blind randomised study of rectal sucralfate suspension in the prevention of acute radiation proctitis. Radiother Oncol. 45:1997;117-123.
14. Taal B.G., Vales-Olmos R.A., Boot H., et al. Assessment of sucralfate coating by sequential scintigraphic imaging in radiation induced oesophageal lesions. Gastrointest Endosc. 41:1995;109-114.
15. Valls A., Pestchen I., Prats C., et al. Multicenter double-blind clinical trial comparing sucralfate vs. placebo in the prevention of diarrhoea secondary to pelvic irradiation. Med Clin. 113:(18):1999;681-684.
16. Wang C.J., Leung S.W., Chen H.C., et al. The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: evidence suggestive of consequential late effect (CQLE). Int J Radiat Oncol Biol Phys. 40:(1):1998;85-91.
17. Wang C., Zheng H., Sung C.C., et al. The synthetic somatostatin analogue, octreotide, ameliorates acute and delayed intestinal radiation injury. Int J Radiat Oncol Biol Phys. 45:(5):1999;1289-1296.